| Serial Number | 90710082 |
| Word Mark | YONZIGDO |
| Filing Date | Thursday, May 13, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, May 29, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 30, 2022 |
| Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 12, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Celgene Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Summit, NJ 07901 |
| Party Name | Celgene Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Summit, NJ 07901 |
| Event Date | Event Description |
| Tuesday, May 30, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, May 29, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, October 25, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 30, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 30, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 10, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, July 28, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, July 28, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, July 28, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, July 28, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, July 28, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, July 18, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 18, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 18, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, January 20, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, January 20, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, January 20, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, January 20, 2022 | ASSIGNED TO EXAMINER |
| Thursday, August 12, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, May 17, 2021 | NEW APPLICATION ENTERED |